Acceptability and feasibility pilot randomised controlled trial of medical skin camouflage for recovery of women prisoners with self-harm scarring (COVER): the study protocol

Heather Mitchell, Kathryn M Abel, Brendan James Dunlop, Tammi Walker, Sandeep Ranote, Louise Robinson, Fiona Edgar, Tracy Millington, Rachel Meacock, Jenny Shaw, Kerry Gutridge, Heather Mitchell, Kathryn M Abel, Brendan James Dunlop, Tammi Walker, Sandeep Ranote, Louise Robinson, Fiona Edgar, Tracy Millington, Rachel Meacock, Jenny Shaw, Kerry Gutridge

Abstract

Introduction: Self-harm in prison is a major public health concern. Less than 5% of UK prisoners are women, but they carry out more than a fifth of prison self-harm. Scars resulting from self-harm can be traumatising and stigmatising, yet there has been little focus on recovery of women prisoners with self-harm scarring. Medical skin camouflage (MSC) clinics treat individuals with disfiguring skin conditions, with evidence of improved well-being, self-esteem and social interactions. Only one community study has piloted the use of MSC for self-harm scarring.

Methods and analysis: We describe an acceptability and feasibility pilot randomised controlled trial; the first to examine MSC for women prisoners who self-harm. We aim to randomise 20-25 women prisoners to a 6-week MSC intervention and 20-25 to a waitlist control (to receive the MSC after the study period). We aim to train at least 6-10 long-term prisoners with personal experience of self-harm to deliver the intervention. Before and after intervention, we will pilot collection of women-centred outcomes, including quality of life, well-being and self-esteem. We will pilot collection of self-harm incidents during the intervention, resources used to manage/treat self-harm and follow-up of women at 12 weeks from baseline. Data on recruitment, retention and dropout will be recorded. We aim for the acceptability of the intervention to prison staff and women prisoners to be explored in qualitative interviews and focus groups.

Ethics and dissemination: Ethical approval for COVER has been granted by the North East-York Research Ethics Committee (REC) for phases 1 and 2 (reference: 16/NE/0030) and West of Scotland REC 3 for phases 3 and 4 (reference: 16/WS/0155). Informed consent will be the primary consideration; it will be made clear that participation will have no effect on life in prison or eligibility for parole. Due to the nature of the study, disclosures of serious self-harm may need to be reported to prison officials. We aim for findings to be disseminated via events at the study prison, presentations at national/international conferences, journal publications, prison governor meetings and university/National Health Service trust communications.

Trial registration number: NCT02638974; Pre-results.

Keywords: feasibility trial; medical skin camouflage; recovery; scarring; self-harm; women prisoners.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.

Figures

Figure 1
Figure 1
Consolidated Standards of Reporting Trials (CONSORT) diagram.

References

    1. National Collaborating Centre for Mental Health. Self-harm: the short-term physical and psychological management and secondary prevention of self-harm in primary and secondary care. London, England: National Institute for Clinical Excellence, 2004.
    1. Hawton K, Arensman E, Townsend E, et al. . Deliberate self harm: systematic review of efficacy of psychosocial and pharmacological treatments in preventing repetition. BMJ 1998;317:441–7. 10.1136/bmj.317.7156.441
    1. Marzano L, Fazel S, Rivlin A, et al. . Psychiatric disorders in women prisoners who have engaged in near-lethal self-harm: case-control study. Br J Psychiatry 2010;197:219–26. 10.1192/bjp.bp.109.075424
    1. Ministry of Justice. Safer in custody statistics England and Wales: deaths in custody to March 2016, Assaults and self-harm in custody to December 2015. London: Ministry of Justice, 2016.
    1. Van Loey NE, Van Son MJ. Psychopathology and psychological problems in patients with burn scars: epidemiology and management. Am J Clin Dermatol 2003;4:245–72. 10.2165/00128071-200304040-00004
    1. Brown BC, McKenna SP, Siddhi K, et al. . The hidden cost of skin scars: quality of life after skin scarring. J Plast Reconstr Aesthet Surg 2008;61:1049–58. 10.1016/j.bjps.2008.03.020
    1. Rumsey N, Clarke A, Musa M. Altered body image: the psychosocial needs of patients. Br J Community Nurs 2002;7:563–6. 10.12968/bjcn.2002.7.11.10886
    1. Levy LL, Emer JJ. Emotional benefit of cosmetic camouflage in the treatment of facial skin conditions: personal experience and review. Clin Cosmet Investig Dermatol 2012;5:173–82. 10.2147/CCID.S33860
    1. Leibenluft E, Gardner DL, Cowdry RW. Special feature the inner experience of the borderline self-mutilator. J Pers Disord 1987;1:317–24. 10.1521/pedi.1987.1.4.317
    1. Chandler A. Narrating the self-injured body. Med Humanit 2014;40:111–6. 10.1136/medhum-2013-010488
    1. McMichael L. Skin camouflage. BMJ 2012;344:d7921.
    1. Holme SA, Beattie PE, Fleming CJ. Cosmetic camouflage advice improves quality of life. Br J Dermatol 2002;147:946–9. 10.1046/j.1365-2133.2002.04900.x
    1. Green L. The effect of skin conditions on patients' quality of life. Nurs Stand 2010;25:48–56. 10.7748/ns.25.9.48.s52
    1. Kent G. Testing a model of disfigurement: effects of a skin camouflage service on well-being and appearance anxiety. Psychol Health 2002;17:377–86. 10.1080/08870440290029601
    1. Tanioka M, Yamamoto Y, Kato M, et al. . Camouflage for patients with vitiligo vulgaris improved their quality of life. J Cosmet Dermatol 2010;9:72–5. 10.1111/j.1473-2165.2010.00479.x
    1. Hayashi N, Imori M, Yanagisawa M, et al. . Make-up improves the quality of life of acne patients without aggravating acne eruptions during treatments. Eur J Dermatol 2005;15:284–7.
    1. McConochie L, Pearson E. Development of a nurse-led skin camouflage clinic. Nurs Stand 2006;20:74–80. 10.7748/ns.20.24.74.s59
    1. Walker T, Shaw J, Ranote S, et al. . Medical skin camouflage: a recovery intervention for female prisoners who self-harm? Crim Behav Ment Health 2014;24:317–20. 10.1002/cbm.1943
    1. Kenning C, Cooper J, Short V, et al. . Prison staff and women prisoner’s views on self-harm; their implications for service delivery and development: A qualitative study. Crim Behav Ment Health 2010;20:274–84. 10.1002/cbm.777
    1. Ranote S. Skin camouflage service: a first for mental health; Innovation to implementation. Talk presented at Self-harm in Women’s Prisons Conference: University of Manchester, 2016.
    1. Faces C. Skin camouflage practitioner training trainer’s practical course manual for COVER Project. London, England: Changing Faces, 2015.
    1. Walker T, Shaw J, Turpin C, et al. . The WORSHIP II study: a pilot of psychodynamic interpersonal therapy with women offenders who self-harm. J Forens Psychiatry Psychol 2017;28:158–71. 10.1080/14789949.2017.1301529
    1. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210–6. 10.1111/j.1365-2230.1994.tb01167.x
    1. Rosenberg M. Society and the adolescent self-image. Princeton, N.J: Princeton University Press, 1965.
    1. Gratz KL. Measurement of deliberate self-harm: preliminary data on the deliberate self-harm inventory. J Psychopathol Behav Assess 2001;23:253–63. 10.1023/A:1012779403943
    1. Zanarini MC, Vujanovic AA, Parachini EA, et al. . Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD): a continuous measure of DSM-IV borderline psychopathology. J Pers Disord 2003;17:233–42. 10.1521/pedi.17.3.233.22147
    1. Tennant R, Hiller L, Fishwick R, et al. . The Warwick-Edinburgh Mental Well-being Scale (WEMWBS): development and UK validation. Health Qual Life Outcomes 2007;5:63 10.1186/1477-7525-5-63
    1. Beck AT, Kovacs M, Weissman A. Assessment of suicidal intention: the Scale for Suicide Ideation. J Consult Clin Psychol 1979;47:343–52. 10.1037/0022-006X.47.2.343
    1. Beck AT, Steer RA, Brown GK. Manual for the BDI-II. San Antonio: TX: Psychological Corporation, 1996.
    1. Wang YP, Gorenstein C. Psychometric properties of the Beck Depression Inventory-II: a comprehensive review. Braz J Psychiatr 2013;35:416–31. 10.1590/1516-4446-2012-1048
    1. Beck AT, Weissman A, Lester D, et al. . The measurement of pessimism: the hopelessness scale. J Consult Clin Psychol 1974;42:861–5. 10.1037/h0037562
    1. Boduszek D, Shevlin M, Mallett J, et al. . Dimensionality and construct validity of the Rosenberg self‐esteem scale within a sample of recidivistic prisoners. J Crim Psychol 2012;2:19–25. 10.1108/20093821211210468
    1. Gusi N, Olivares PR, Rajendram R. The EQ-5D Health-related quality of life questionnaire. USA, New York: Springer, 2010:87–99.
    1. Haywood KL, Garratt AM, Dziedzic K, et al. . Generic measures of health-related quality of life in ankylosing spondylitis: reliability, validity and responsiveness. Rheumatology 2002;41:1380–7. 10.1093/rheumatology/41.12.1380
    1. Ware J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220–33.
    1. Barrett B, Byford S. Collecting service use data for economic evaluation in DSPD populations: development of the Secure Facilities Service Use Schedule. Br J Psychiatry Suppl 2007;49:s79 10.1192/bjp.190.5.s75
    1. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006;3:77–101. 10.1191/1478088706qp063oa
    1. Boyatzis R. Transforming qualitative information: thematic analysis and code development. California: Sage, 1998.
    1. Mays N, Pope C. Qualitative research: rigour and qualitative research. BMJ 1995;311:109–12. 10.1136/bmj.311.6997.109

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다